Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
503.60
-12.80 (-2.48%)
Mar 7, 2025, 9:15 AM IST
Akums Drugs and Pharmaceuticals Employees
Akums Drugs and Pharmaceuticals had 7,388 employees as of March 31, 2024. The number of employees decreased by 7,612 or -50.75% compared to the previous year.
Employees
7,388
Change (1Y)
-7,612
Growth (1Y)
-50.75%
Revenue / Employee
5.43M INR
Profits / Employee
202.00K INR
Market Cap
79.96B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 7,388 | -7,612 | -50.75% |
Mar 31, 2023 | 15,000 | 477 | 3.28% |
Mar 31, 2022 | 14,523 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 9,741 |
Cipla | 27,764 |
Mankind Pharma | 19,540 |
Zydus Lifesciences | 26,921 |
Apollo Hospitals Enterprise | 83,147 |
Aurobindo Pharma | 26,015 |
Alkem Laboratories | 17,432 |
Akums Drugs and Pharmaceuticals News
- 7 weeks ago - Akums Drugs and Pharmaceuticals shares fall over 6% following Income Tax Department search - Business Upturn
- 2 months ago - Akums Drugs secures Rs 1,760 deal to supply oral liquid formulations in Europe - Business Upturn
- 3 months ago - Akums Drugs partners with Jagdale to revolutionize India’s Ready-to-Drink nutritional beverage market - Business Upturn
- 4 months ago - Akums Drugs shares surge 5% after signing Master Sales Agreement with Caregen - Business Upturn
- 4 months ago - Akums Drugs signs Master Sales Agreement with Caregen for Indian Nutraceutical market expansion - Business Upturn
- 4 months ago - Akums Drugs and Pharmaceuticals shares fall 5% following weak Q2 earnings outlook - Business Upturn
- 4 months ago - Akums Drugs and Pharmaceuticals Q2 FY25 results: Revenue at ₹1,033.09 crore, down 12.5% YoY; profit at ₹66.65 crore, up 103.8% YoY - Business Upturn
- 5 months ago - Akums Drugs signs MoU with Zambian Ministry of Health to manufacture local medicine - Business Upturn